Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hypertension

  Free Subscription


Articles published in J Cardiovasc Pharmacol

Retrieve available abstracts of 25 articles:
HTML format



Single Articles


    November 2021
  1. TEMIZ-RESITOGLU M, Guden DS, Senol SP, Vezir O, et al
    Pharmacological inhibition of mTOR attenuates DOCA-salt-induced hypertension and related pathophysiology: regulation of oxidative stress, inflammation and cardiovascular hypertrophy in male rats.
    J Cardiovasc Pharmacol. 2021 Nov 23. pii: 00005344-900000000-98105.
    PubMed     Abstract available


    October 2021
  2. ZHU T, Wang X, Zheng Z, Quan J, et al
    ZIP12 Contributes to Hypoxic Pulmonary Hypertension by Driving Phenotypic Switching of Pulmonary Artery Smooth Muscle Cells.
    J Cardiovasc Pharmacol. 2021 Oct 21. pii: 00005344-900000000-98129.
    PubMed     Abstract available


  3. ABDELMONEM M, Ebada MA, Diab S, Ahmed MM, et al
    Efficacy of Hibiscus Sabdariffa on Reducing Blood Pressure in Patients with Mild to Moderate Hypertension: A Systematic Review and Meta-Analysis of published randomized controlled trials.
    J Cardiovasc Pharmacol. 2021 Oct 20. pii: 00005344-900000000-98127.
    PubMed     Abstract available


  4. ADIE SK, Abdul-Aziz AA, Ketcham SW, Moles VM, et al
    Considerations for inotrope and vasopressor use in critically ill patients with pulmonary arterial hypertension.
    J Cardiovasc Pharmacol. 2021 Oct 6. pii: 00005344-900000000-98139.
    PubMed     Abstract available


    August 2021
  5. LUO S, Kan J, Zhang J, Ye P, et al
    Bioactive Compounds From Coptidis Rhizoma Alleviate Pulmonary Arterial Hypertension by Inhibiting Pulmonary Artery Smooth Muscle Cells' Proliferation and Migration.
    J Cardiovasc Pharmacol. 2021;78:253-262.
    PubMed     Abstract available


    July 2021
  6. PENG M, He J, Xue Y, Yang X, et al
    The role of hypertension on the severity of COVID-19: a review.
    J Cardiovasc Pharmacol. 2021 Jul 22. pii: 00005344-900000000-98170.
    PubMed     Abstract available


  7. KRYSIAK R, Basiak M, Okopien B
    Impact of lisinopril on cardiometabolic risk factors in men with hypertension and early-onset androgenetic alopecia: a pilot study.
    J Cardiovasc Pharmacol. 2021 Jul 20. pii: 00005344-900000000-98169.
    PubMed     Abstract available


  8. WANG Y, Wang JW, Wang Y, Yang B, et al
    Monitoring Antihypertensive Medication Adherence by LC-MS/MS: Method Establishment and Clinical Application.
    J Cardiovasc Pharmacol. 2021 Jul 9. pii: 00005344-900000000-98173.
    PubMed     Abstract available


    June 2021
  9. HAMMOUD S, Kurdi M, van den Bemt BJ
    Impact of Fasting on Cardiovascular Outcomes in Patients with Hypertension.
    J Cardiovasc Pharmacol. 2021 Jun 29. pii: 00005344-900000000-98181.
    PubMed     Abstract available


    May 2021
  10. YANG S, Zhang H, Yang P, Wang C, et al
    Efficacy and Safety of LCZ696 for Short-term Management of Essential Hypertension Compared With ARBs: A Meta-analysis of Randomized Controlled Trials.
    J Cardiovasc Pharmacol. 2021;77:650-659.
    PubMed     Abstract available


    April 2021
  11. MCCOY EK, Lisenby KM
    Aprocitentan (a dual endothelin receptor antagonist) for Treatment-Resistant Hypertension.
    J Cardiovasc Pharmacol. 2021 Apr 5. pii: 00005344-900000000-98239.
    PubMed     Abstract available


  12. YAMAGATA K, Yamori Y
    Altered properties of neurons and astrocytes and the effects of food components in stroke-prone spontaneously hypertensive rats.
    J Cardiovasc Pharmacol. 2021 Apr 5. pii: 00005344-900000000-98237.
    PubMed     Abstract available


  13. GILEWSKI W, Banach J, Rogowicz D, Wolowiec L, et al
    Treatment of hypertension due to immunosuppressive therapy after solid organ transplantation - pharmacological approach.
    J Cardiovasc Pharmacol. 2021 Apr 5. pii: 00005344-900000000-98236.
    PubMed     Abstract available


    March 2021
  14. RAJABI S, Najafipour H, Farsangi SJ, Joukar S, et al
    Quercetin, Perillyl alcohol and Berberine ameliorate right ventricular disorders in experimental pulmonary arterial hypertension: Effects on miR-204, miR-27a, fibrotic, apoptotic and inflammatory factors.
    J Cardiovasc Pharmacol. 2021 Mar 12. pii: 00005344-900000000-98234.
    PubMed     Abstract available


    February 2021
  15. VILHENA JC, Lopes de Melo Cunha L, Jorge TM, de Lucena Machado M, et al
    Acai reverses adverse cardiovascular remodeling in renovascular hypertension: a comparative effect with Enalapril.
    J Cardiovasc Pharmacol. 2021 Feb 19. pii: 00005344-900000000-98275.
    PubMed     Abstract available


  16. GAO HL, Yu XJ, Liu KL, Zuo YY, et al
    Chronic Infusion of Astaxanthin Into Hypothalamic Paraventricular Nucleus Modulates Cytokines and Attenuates the Renin-Angiotensin System in Spontaneously Hypertensive Rats.
    J Cardiovasc Pharmacol. 2021;77:170-181.
    PubMed     Abstract available


    November 2020
  17. RIGOPOULOS AG, Kalogeropoulos AS, Tsoporis JN, Sakadakis EA, et al
    Heat shock protein 70 is associated with cardioversion outcome and recurrence of symptomatic recent onset atrial fibrillation in hypertensive patients.
    J Cardiovasc Pharmacol. 2020 Nov 24. doi: 10.1097/FJC.0000000000000962.
    PubMed     Abstract available


  18. MAQSOOD MH, Rubab K, Anwar F, Afzal Khan MT, et al
    A Systematic Review of Randomized Controlled Trials Comparing Renal Sympathetic Denervation versus Sham Procedure for the Management of Uncontrolled Hypertension.
    J Cardiovasc Pharmacol. 2020 Nov 20. doi: 10.1097/FJC.0000000000000961.
    PubMed     Abstract available


  19. LU J, Tian Y, Gu J, Qiu M, et al
    Comparative study of metabolite changes after antihypertensive therapy with calcium channel blockers or angiotensin type 1 receptor blockers.
    J Cardiovasc Pharmacol. 2020 Nov 17. doi: 10.1097/FJC.0000000000000958.
    PubMed     Abstract available


    October 2020
  20. REGINA SM, Maria L, Reinhold F, Elisabeth S, et al
    Rapid Switch from Subcutaneous to Intravenous Treprostinil in Precapillary Pulmonary Hypertension by Pump Implantation.
    J Cardiovasc Pharmacol. 2020 Oct 15. doi: 10.1097/FJC.0000000000000933.
    PubMed     Abstract available


  21. DE JESUS SILVA F, Drummond FR, Fidelis MR, Freitas MO, et al
    Continuous aerobic exercise prevents detrimental remodeling and right heart myocyte contraction and calcium cycling dysfunction in pulmonary artery hypertension.
    J Cardiovasc Pharmacol. 2020 Oct 9. doi: 10.1097/FJC.0000000000000928.
    PubMed     Abstract available


    September 2020
  22. SOUZA-PAULA E, Polonio LCC, Zochio GP, Pinho da Silva K, et al
    Anticontractile effect of perivascular adipose tissue but not of endothelium is enhanced by hydrogen sulfide stimulation in hypertensive pregnant rat aortae.
    J Cardiovasc Pharmacol. 2020 Sep 18. doi: 10.1097/FJC.0000000000000917.
    PubMed     Abstract available


    June 2020
  23. TANG M, Wang R, Feng P, Dong Q, et al
    Dihydroartemisinin Attenuates Pulmonary Hypertension via Inhibition of Pulmonary Vascular Remodeling in Rats.
    J Cardiovasc Pharmacol. 2020 Jun 5. doi: 10.1097/FJC.0000000000000862.
    PubMed     Abstract available


    May 2020
  24. GRZESK G, Karasek D, Kusiak M
    Thrombocytopenia During Prostacyclin Analogue Therapies of Pulmonary Arterial Hypertension-Possible Pathomechanisms and Implications.
    J Cardiovasc Pharmacol. 2020;75:421-425.
    PubMed     Abstract available


    April 2020
  25. HOPPER RK, Ivy DD, Yung D, Mullen MP, et al
    Pharmacokinetics of Oral Treprostinil in Children with Pulmonary Arterial Hypertension.
    J Cardiovasc Pharmacol. 2020 Apr 16. doi: 10.1097/FJC.0000000000000842.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: